ACTRN12605000464662进行中（未招募）1 期
CTRG B09/00 A phase I/II study of weekly paclitaxel, UFT, and leucovorin in patients with metastatic breast cancer
CTRG initiated study0 个研究点目标入组 60 人开始时间: 2005年9月23日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- ot stated 至 ot stated（—）
- 性别
- Female
入选标准
- •First line metastatic, female, adequate haematological, renal and hepatic function.
排除标准
- •No exclusion criteria
研究者
相似试验
已完成
不适用
A randomised trial of maintenance weekly paclitaxel versus observation following remission with first-line induction carboplatin and paclitaxel for patients with ovarian cancerMalignant neoplasm of ovaryCancerOvarian cancerISRCTN48397858The Institute of Cancer Research (UK)1,200
进行中（未招募）
2 期
Biweekly chemotherapy with nab-Paclitaxel plus Gemcitabine for elderly patinents of unresectable pancreatic cancerPancreatic cancerJPRN-jRCTs051190038Ikezawa Kenji20
已完成
1 期
A phase I study of bi-weekly carboplatin/paclitaxel chemotherapy in elderly advanced non-small cell lung canceron-small-cell lung cancerJPRN-UMIN000005263Shimane University Faculty of Medicine, Division of Clinical Oncology and Respiratory Medicine11
已完成
2 期
A phase II study of weekly paclitaxel for advanced or recurrent esophageal canceradvanced or reccurent esophageal cancerJPRN-UMIN000009807Medical Oncology, Hirosaki University Graduate School of Medicine30
已完成
2 期
Phase II study of weekly paclitaxel (wP) followed by doxorubicin plus paclitaxel (AP) as neo-adjuvant chemotherapy for triple negative Breast Cancer (WePAP)Primary breast cancerJPRN-UMIN000001205Saitama Breast Cancer Clinical Study Group (SBCCSG)63